Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6797.5000 139.50 (2.10%)

NSE Jun 30, 2025 14:16 PM

Near 52W High of ₹6862.50

Volume: 409.6K

Divi's Laboratories Ltd.

25 May 2024

6797.50

2.10%

Divi's Labs (SELL): Strong quarter; rich valuations

Sell: Divi's Laboratories Ltd.

BOB Capital Markets Ltd.

DIVI delivered a strong quarter with all round beat. EBITDA/PAT beat Bloomberg consensus estimate by 20% each

Divi's Laboratories Ltd. is trading above all available SMAs